Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHROMIUM study of Seroquel SR monotherapy in elderly patients with generalized anxiety disorder
2006-001195-21Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Seroquel SR monotherapy with Placebo (2 arms). Primary endpoint: Change from randomization in HAM-A total score at Day 64. Started May 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on 2006-001195-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001195-21.